Michell G.
AeroLeads people directory · profile

Michell G. Email & Phone Number

Regional Business Director GYN Oncology - South Central at Corcept Therapeutics
Location: Dallas-Fort Worth Metroplex, United States 10 work roles 2 schools
LinkedIn matched
✓ Verified July 2026 3 data sources Profile completeness 86%

Contact Signals

LinkedIn Profile matched
3 free lookups remaining · No credit card
Current company
Role
Regional Business Director GYN Oncology - South Central
Location
Dallas-Fort Worth Metroplex, United States
Company size

Who is Michell G.? Overview

A concise factual answer block for searchers comparing this professional profile.

Quick answer

Michell G. is listed as Regional Business Director GYN Oncology - South Central at Corcept Therapeutics, a with 621 employees, based in Dallas-Fort Worth Metroplex, United States. AeroLeads shows a matched LinkedIn profile for Michell G..

Michell G. previously worked as Sr Regional Business Director at Agios Pharmaceuticals and Director, Commercial Business Operations at Seagen. Michell G. holds Ba, English from Saint Louis University.

Company email context

Email format at Corcept Therapeutics

This section adds company-level context without repeating Michell G.'s masked contact details.

Corcept Therapeutics

Review company-level records connected to Michell G. before choosing the right outreach path.

Profile bio

About Michell G.

Michell is a strategic, authentic, forward-thinking and enterprise-oriented transformational leader with over 10 years of sales leadership experience in oncology and rare disease in both large and start-up biotech companies. Focused on breaking down silos, vertical and horizontal collaboration with cross functional teams, expanding capabilities, coaching and mentoring. Masterful at architecting high performance work cultures, developing and retaining top talent while also empowering individuals to tap into their strengths to drive performance and enhance peer leadership. Consistent track record of exceeding goals and delivering on portfolio strategic imperatives. Michell believes in transparency, accountability, humility and integrity - these embody her moral compass.

Current workplace

Michell G.'s current company

Company context helps verify the profile and gives searchers a useful next step.

Corcept Therapeutics
Corcept Therapeutics
Regional Business Director GYN Oncology - South Central
Texas, United States
Website
Employees
621
AeroLeads page
10 roles

Michell G. work experience

A career timeline built from the work history available for this profile.

Director, Commercial Business Operations

Dallas, Texas, United States

Promoted to lead and execute upon all operational aspects of the marketing process in support of the US Commercial organization's promotional activities across 4 brands, optimizing the group's effectiveness to support commercial efforts in the US. Responsibilities included oversight of medical, regulatory, legal review of processes, execution of Speaker Program Operations, Promotional Materials Management, Internal Meetings, Contract Administration, Congress Planning in partnership with Medical Affairs and Brand Leads, and Budget Operations in partnership with Legal, Procurement and Brand teams. (This was a second line leadership role. Pfizer acquired SeaGen December 2023.)

Mar 2023 - Jun 2024

Division Manager West (Hybrid Dm/Rsd) - Tisotumab Vedotin Franchise

Seagen (Oncology/Rare Disease/Start Up Gyn/Onc Franchise)

Western Half Of Us (Including Ak & Hi)

Recruited, hired and led a team of 6 Senior Oncology Account Managers and 1 Remote Sales Specialist to launch the first ADC, tivdak, in metastatic and recurrent cervical cancer (product was co-promoted with Genmab.). Ensured team had the right resources to successfully execute on identified business opportunities. Division finished #1, with Circle of Excellence Award. Demonstrated a commitment to people development by spearheading a cross franchise talent development task force. Initiative was recognized with a Field Leadership Award. One direct report promoted to Assoc Dir, Market Development.

Apr 2021 - Mar 2023

Regional Business Manager - Gulfcoast

Urogen Pharma - Oncology (Rare Disease/Start Up)

Az, Nm, Tx, La, Ms, Al, Ar, Tn, Fl Panhandle

Built and led a team of 7 Territory Business Managers, 1 Clinical Nurse Educator and 1 Field Reimbursement Manager to launch a novel technology, JELMYTO, for instillation at Ambulatory Surgical Centers/Hospitals as first non-surgical treatment for patients with low grade upper tract urothelial cancer to UroOncologists and Medical Oncologists at leading academic institutions and LUGPA accounts in Gulf Coast Region. One direct report promoted to Key Account Manager.

Aug 2019 - Apr 2021

Division Manager - Southwest

Clovis Oncology (Rare Disease/Start Up)

Tx, Ok, Nm

One of first 175 employees hired to build and lead a team of 8 Territory Managers, responsible for commercialization of an FDA Designated Breakthrough Therapy. Product: Rucaparib (PARP Inhibitor – Medicare Part D.) Tumor line – Advanced Ovarian. - 2019 - Number 1 in the nation YTD thru August - 2018 Finished the year 115% to goal, #2 in country. APEX Award Winner (Highest Sales Achievement awarded to top 2 divisions in the nation.) - 2017 Key Launch Achievement - 142% to launch goal attainment, maximizing highest tier of Sales Excellence - Two direct reports promoted into Marketing and Market Access roles

Jun 2015 - Aug 2019

District Sales Manager - Southwest

Celgene (Oncology)

Tx, Nm, Az, Wy, Id, Ut

Led a team of 7 Hematology Oncology Consultants. Tumor lines: mBC, mNSCLC, mPAC. Product: Abraxane® (Medicare Part B). • 101.7% to goal attainment Q1’2015 (12,774 vials), finishing ahead of the region (95.94% to goal) and the nation (97.30% to goal)• Developed and led a 1-day Texas Oncology Task Force Strategy Planning Meeting resulting in strategic alignment, collaboration and accountability across multiple internal stakeholders

Nov 2014 - May 2015

Regional Sales Director Oncology - Southwest

Gsk (Oncology)

Tx/Nm

-Led a team of 8 Oncology Account Specialists, covering Community Oncology Clinics across Texas and New Mexico. -Led team through successful launch of FDA Breakthrough Designation melanoma product, Tafinlar/Mekinist, in the oral marketplace. Additional solid tumor and hematology products included: Promacta, Votrient and Arzerra.-Oncology business unit was acquired by Novartis

Jul 2013 - Oct 2014

District Sales Manager Oncology - Midatlantic

Amgen (Oncology)

Washington D.C., Md, Va, W. Va, Pa

• Promoted to lead a team of 6 HSM’s (Hospital System Managers), who combined managed 21 Academic, DoD and VA Accounts, including UPMC, Georgetown, Johns Hopkins, Walter Reed National Military Medical Center and Washington Hospital Center. Portfolio: Xgeva, Neulasta, Aranesp, Nplate, Vectibix• Held team accountable to execution of regional/district strategies, contract pull through and delivering consistent sales results and unit growth of all brands semester over semester.

Sep 2009 - Jul 2013

Regional Hospital Manager - Southeast Region (Oncology)

La, Ms, Al, Ga, Fl, Pr, Tn, Mo

Promoted to manage key hospital accounts - South East Region. Reported to Executive Director of Regional Sales and worked alongside District Sales Managers to identify growth opportunities, strategically win new business and mitigate competitive threats.• #1 Region in the Nation 2008• Multiple formulary wins over 1½ year period in a highly competitive market.• Established and strengthened business relationships with administrators, GPO’s, pharmacy directors and clinical oncology and nephrology pharmacists• Collaborated with Clinical Specialist team, Brand Teams, Nephrology Business Unit and Health System Manager Team to discuss market dynamics, account planning, strategy and pull through, GPO corporate direction, contracting and competitive information.

Mar 2008 - Sep 2009
Team & coworkers

Colleagues at Corcept Therapeutics

Other employees you can reach at agios.com. View company contacts for 621 employees →

2 education records

Michell G. education

FAQ

Frequently asked questions about Michell G.

Quick answers generated from the profile data available on this page.

What company does Michell G. work for?

Michell G. works for Corcept Therapeutics.

What is Michell G.'s role at Corcept Therapeutics?

Michell G. is listed as Regional Business Director GYN Oncology - South Central at Corcept Therapeutics.

Where is Michell G. based?

Michell G. is based in Dallas-Fort Worth Metroplex, United States while working with Corcept Therapeutics.

What companies has Michell G. worked for?

Michell G. has worked for Corcept Therapeutics, Agios Pharmaceuticals, Seagen, Seagen (Oncology/Rare Disease/Start Up Gyn/Onc Franchise), and Urogen Pharma - Oncology (Rare Disease/Start Up).

Who are Michell G.'s colleagues at Corcept Therapeutics?

Michell G.'s colleagues at Corcept Therapeutics include Gonzalo F., Mark Fletcher, Amol Basgunde, Matt Johnson, and Jerry Langlois.

How can I contact Michell G.?

You can use AeroLeads to view verified contact signals for Michell G. at Corcept Therapeutics, including work email, phone, and LinkedIn data when available.

What schools did Michell G. attend?

Michell G. holds Ba, English from Saint Louis University.

Find 750M verified contacts

Search by job title, company, industry, location, and seniority. Export verified B2B contact data when you need it.

People with similar names

Check these profiles if this is not the Michell G. you were looking for.

View similar profiles